BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 65.98
+0.74 (1.13%)
At close: Jan 21, 2026
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €12.88 billion as of January 22, 2026. Its market cap has increased by 147.78% in one year.
Market Cap
12.88B
Enterprise Value
13.92B
Revenue
301.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€65.98
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 12.88B, an increase of 340.86%. That is a compound annual growth rate of 25.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 12.68B | 0.99% |
| Dec 31, 2025 | 12.55B | 150.63% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Terna | 18.23B |
| Banca Mediolanum | 14.30B |
| Unipol Assicurazioni | 14.26B |
| Mediobanca Banca di Credito Finanziario | 13.86B |
| FinecoBank Banca Fineco | 13.61B |
| Moncler | 13.46B |
| Telecom Italia | 12.53B |
| Edison | 11.32B |